Table 2.
Crack and other drug use characteristics of samples
| |
Street sample (n = 81) |
Treatment sample (n = 30) |
||||
|---|---|---|---|---|---|---|
| N | % | 95% CI | n | % | 95% CI | |
|
Shared crack implements [30] [*] |
|
|
|
|
|
|
| Yes |
49 |
60 |
49–71 |
8 |
27 |
11–43 |
| No |
32 |
40 |
29–51 |
22 |
73 |
57–89 |
|
Shared >10 time (among sharers) |
|
|
|
|
|
|
| Yes |
33 |
67 |
54–80 |
3 |
38 |
4–72 |
| No |
16 |
33 |
20–46 |
5 |
62 |
28–96 |
|
Drug injection history (ever) |
|
|
|
|
|
|
| Yes |
0 |
n/a |
n/a |
1 |
3 |
n/a |
| No |
81 |
100 |
n/a |
29 |
97 |
91–100 |
|
Use of other drugs [30] |
|
|
|
|
|
|
| Alcohol [*] |
21 |
34 |
22–46 |
13 |
65 |
43–85 |
| Tobacco |
70 |
92 |
86–98 |
25 |
96 |
89–100 |
| Cocaine |
14 |
26 |
14–38 |
9 |
45 |
23–67 |
| Marijuana |
42 |
64 |
52–76 |
19 |
66 |
49–83 |
| Benzodiazepines |
0 |
n/a |
n/a |
1 |
33 |
n/a |
| Inhalants (e.g., glue, solvents) | 2 | 5 | 0–12 | 2 | 20 | 0–43 |
Notes:
[30]: In past 30 days.
[*] Chi-square significant at p < 0.05 level.